Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018

H.R. 5333 · 115th Congress · Jul 17, 2018 · Lineage

AN ACT

To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.

Section 1 Short title

This Act may be cited as the “Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018”.

Lineage

Jul 17, 2018viewing Placed on Calendar Senate Received; read twice and placed on the calendar See what changed
Jul 16, 2018 Engrossed in House See what changed
Mar 19, 2018 Reported in House Mr. Latta (for himself, Mr. Burgess, Mr. Gene Green of Texas, Ms. DeGette, Mr. Guthrie, and Mrs. Dingell) introduced the following bill; which was referred to the Committee on Energy and Commerce See what changed
Mar 19, 2018 Introduced in House Mr. Latta (for himself, Mr. Burgess, Mr. Gene Green of Texas, Ms. DeGette, Mr. Guthrie, and Mrs. Dingell) introduced the following bill; which was referred to the Committee on Energy and Commerce

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018

Section 1 Short title

Cite this provision

Incoming references